Codexis Aktie

Codexis EBITDA

EBITDA (Indtjening før renter, skatter, af- og nedskrivninger) for Codexis (CDXS) pr. 12. aug. 2026 er -41,74 Mio. USD. I foregående år var EBITDA (Indtjening før renter, skatter, af- og nedskrivninger) -53,67 Mio. USD — en ændring på -22,24 % (højere).

EBITDA

-41,74 Mio.USD

YoY

-22,24%

Senest opdateret:

EBITDA (Indtjening før renter, skatter, af- og nedskrivninger) for Codexis er 2026 -41,74 Mio. USD. EBITDA (Indtjening før renter, skatter, af- og nedskrivninger) for Codexis var 2025 -53,67 Mio. USD. Det falder dermed med -22,24% højere sammenlignet med året før.
Access this data via the Eulerpool API

Codexis Aktieanalyse

Hvad laver Codexis? Codexis Inc. is an American biotechnology company that specializes in developing innovative biological solutions for a variety of industries. The company was founded in 2002 and is headquartered in Redwood City, California. Business Model: Codexis is service-oriented and provides customized enzyme solutions for companies looking to improve their products through sustainable processes. The company has developed a unique platform called Rational Protein Engineering, which allows for the development of specific enzymes for various industries. Customers benefit from enzyme optimization expertise and know-how. Divisions: Codexis operates in the fields of life sciences, materials science, agrochemicals, and biofuels. 1. Life Sciences: Codexis specializes in the production of enzymes and biocatalysts for the pharmaceutical industry in the life sciences division. The goal is to provide a faster and more efficient manufacturing process for pharmaceutical active ingredients. The company has successfully developed active ingredients for antibodies, lipids, uric acid, and antivirals. 2. Materials Science: In the materials science division, Codexis specializes in the production of enzymes for materials such as dyes, polymers, and cosmetic products. Codexis ensures that these products are efficiently manufactured without the use of environmentally harmful chemicals. 3. Agrochemicals: Codexis offers customized enzyme solutions to agrochemical manufacturers that reduce the use of chemicals and benefit the environment. These enzymes help in the production of pesticides and other agrochemicals. 4. Biofuels: In the biofuels division, Codexis specializes in the production of enzymes for processing corn, harvested plants, or waste products. These enzymes help enable cost-effective biofuel production. Products: Codexis has developed a wide range of products tailored to the needs of various industries. Some of the products recently introduced to the market by Codexis include: 1. CodeEvolver: CodeEvolver is a platform that allows biotechnology companies to quickly create customized enzyme solutions for their specific needs. The process is fully automated and results in a significant reduction in development time and costs. 2. Codex® screening panels: Codexis offers various screening panels that allow customers to quickly and efficiently select the enzymes best suited for their purposes. The panels are suitable for industries including pharmaceuticals, chemicals, and plant protection. 3. Codex® enzymes: Codexis offers a wide range of enzymes specifically designed for different industry needs. This includes enzymes for the production of biofuels, pesticides, cosmetic products, and pharmaceuticals. Overall, Codexis Inc. has demonstrated its ability to deepen the understanding of biocatalysts and introduce innovative biological processes in a variety of industries through its unique Rational Protein Engineering platform. Codexis er et af de mest populære virksomheder på Eulerpool.com.

Hyppigt stillede spørgsmål om Codexis aktie

EBITDA (Indtjening før renter, skatter, af- og nedskrivninger) for Codexis er -41,74 Mio. USD i 2026.

EBITDA (Indtjening før renter, skatter, af- og nedskrivninger) for Codexis ændrede sig fra -53,67 Mio. USD til -41,74 Mio. USD, hvilket repræsenterer en ændring på -22,24 %. Værdien er højere end i foregående år.

På Eulerpool kan du finde den fuldstændige historiske udvikling af EBITDA (Indtjening før renter, skatter, af- og nedskrivninger) Codexis siden 2006 – med årlige værdier, diagrammer og detaljeret analyse.

EBITDA måler driftsresultatet før virkningen af finansieringsstruktur, skattesystem og ikke-kontante afskrivninger.

EBITDA = EBIT + Af- og nedskrivninger

EBITDA (Indtjening før renter, skatter, af- og nedskrivninger)s USD er en vigtig faktor for investorer. Ændringer i denne nøgletal kan signalere forbedrede eller forværrede fundamentale forhold, hvilket kan påvirke aktiekursen. På Eulerpool kan du følge EBITDA (Indtjening før renter, skatter, af- og nedskrivninger)s Codexis historisk.

Access this data via the Eulerpool API

Resultatopgørelse — Codexis

Alle nøgletal — Codexis